Komori
Okamoto Industries (5122) · InitiativeRestated

Enhancing Product Value and Quality through R&D Investment

First written in FY2016. 29 of 30 entries say "Restated". Latest entry: FY2024-Q3.

30entries
9years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseRestatedFY2016 – FY2024-Q32016: 320162017: 420172018: 420182019: 420192020: 320202021: 320212022: 420222023: 420232024: 1
Same theme, other companies
Continuation of R&D activities with no change in statusA theme 192 companies write about · 0 as a headwind · 181 as a tailwind

96 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 192 companies compared. The sentences above are computed from all 192.
Full recordFilings, disclosures and news, newest first
  1. FY2024-Q3RestatedAnnual report

    「Research and development expenses totaled ¥1,008 million for the nine-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the fiscal year under review.」

    While stating that there were no material changes in research and development activities, the company reports research and development expenses of ¥1,008 million for the nine-month period of the fiscal year under review.
  2. FY2024-Q2RestatedAnnual report

    「Research and development expenses totaled ¥683 million for the six-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the six-month period of the fiscal year under review.」

    The company reconfirms that there were no material changes in research and development activities and reports research and development expenses of ¥683 million for the six-month period of the fiscal year under review.
  3. FY2024-Q1RestatedAnnual report

    「Research and development expenses totaled ¥318 million for the first quarter of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the first quarter of the fiscal year under review.」

    The company reconfirms that there were no material changes in research and development activities and reports research and development expenses of ¥318 million for the first quarter of the fiscal year under review.
  4. FY2023RestatedAnnual report

    「Going forward, we will continue to actively develop and provide environmentally friendly products that consumers consistently demand and that are useful in people’s daily lives.」

    The company continues research and development, including for environmentally friendly products, and reported research and development expenses of ¥1,583 million for the fiscal year.
  5. FY2023-Q3RestatedAnnual report

    「Research and development expenses totaled ¥1,004 million for the nine-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the fiscal year under review.」

    The company reconfirms that there were no material changes in research and development activities and reports research and development expenses of ¥1,004 million for the nine-month period of the fiscal year under review.
  6. FY2023-Q2RestatedAnnual report

    「Research and development expenses totaled ¥674 million for the six-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the six-month period of the fiscal year under review.」

    The company states that there were no material changes in research and development activities and reports research and development expenses of ¥674 million for the six-month period of the fiscal year under review.
  7. FY2023-Q1RestatedAnnual report

    「Research and development expenses totaled ¥335 million for the first quarter of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the first quarter of the fiscal year under review.」

    The company reconfirms that there were no material changes in research and development activities and reports research and development expenses of ¥335 million for the first quarter of the fiscal year under review.
  8. FY2022RestatedAnnual report

    「Research and development for industrial products is currently conducted mainly at the Shizuoka Research and Development Center, while research and development for household products is conducted mainly at the Ibaraki Research and Development Center. The Group’s total research and development expenses for the fiscal year under review were ¥1,594 million.」

    The company continues to operate a structure centered on the Shizuoka and Ibaraki research and development centers and reports research and development expenses of ¥1,594 million for the fiscal year.
  9. FY2022-Q3RestatedAnnual report

    「Research and development expenses totaled ¥990 million for the nine-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the fiscal year under review.」

    While stating that there were no material changes in research and development activities, the company reports research and development expenses of ¥990 million for the nine-month period of the fiscal year under review.
  10. FY2022-Q2RestatedAnnual report

    「Research and development expenses totaled ¥650 million for the six-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the six-month period of the fiscal year under review.」

    While stating that there were no material changes in research and development activities, the company reports research and development expenses of ¥650 million for the six-month period of the fiscal year under review.
  11. FY2021RestatedAnnual report

    「Research and development for industrial products is currently conducted mainly at the Shizuoka Research and Development Center, while research and development for household products is conducted mainly at the Ibaraki Research and Development Center. The Group’s total research and development expenses for the fiscal year under review were ¥1,358 million.」

    The company continues to operate a structure centered on the Shizuoka and Ibaraki research and development centers and reports research and development expenses of ¥1,358 million for the fiscal year.
  12. FY2021-Q3RestatedAnnual report

    「Research and development expenses totaled ¥939 million for the nine-month period of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the nine-month period of the fiscal year under review.」

    While stating that there were no material changes in research and development activities, the company reports research and development expenses of ¥939 million for the nine-month period.
  13. FY2021-Q1RestatedAnnual report

    「Research and development expenses totaled ¥332 million for the first quarter of the fiscal year under review. There were no material changes in the status of the Group’s research and development activities during the first quarter of the fiscal year under review.」

    While stating that there were no material changes in research and development activities, the company reports research and development expenses of ¥332 million for the first quarter of the fiscal year under review.
  14. FY2020RestatedAnnual report

    「R&D on industrial products is currently conducted primarily at the Shizuoka R&D Center, while R&D on household products is conducted primarily at the Ibaraki R&D Center. The Group’s total R&D expenses for the current fiscal year were ¥1,149 million.」

    The Company continues to operate an R&D structure centered on its Shizuoka and Ibaraki R&D centers, with R&D expenses for the year reported at ¥1,149 million.
  15. FY2020-Q3RestatedAnnual report

    「Total R&D expenses for the first nine months of the current fiscal year were ¥846 million. There were no material changes in the status of the Group’s R&D activities during the first nine months of the current fiscal year.」

    Although there were no material changes in R&D activities, cumulative R&D expenses for the first nine months of the current fiscal year were reported at ¥846 million.
  16. FY2020-Q2RestatedAnnual report

    「Total R&D expenses for the first half of the current fiscal year were ¥552 million. There were no material changes in the status of the Group’s R&D activities during the first half of the current fiscal year.」

    Although there were no material changes in R&D activities, cumulative R&D expenses for the first half of the current fiscal year were reported at ¥552 million.
  17. FY2020-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current fiscal year were ¥284 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the quarter were ¥284 million.
  18. FY2019RestatedAnnual report

    「R&D on industrial products is currently conducted primarily at the Shizuoka R&D Center, while R&D on household products is conducted primarily at the Ibaraki R&D Center. The Group’s total R&D expenses for the current fiscal year were ¥1,051 million.」

    The Company continues to operate an R&D structure centered on its Shizuoka and Ibaraki R&D centers, with R&D expenses for the year reported at ¥1,051 million.
  19. FY2019-Q3RestatedAnnual report

    「Total R&D expenses for the first nine months of the current fiscal year were ¥756 million. There were no material changes in the status of the Group’s R&D activities during the first nine months of the current fiscal year.」

    Although there were no material changes in R&D activities, cumulative R&D expenses for the first nine months of the current fiscal year were reported at ¥756 million.
  20. FY2019-Q2RestatedAnnual report

    「Total R&D expenses for the first half of the current fiscal year were ¥510 million. There were no material changes in the status of the Group’s R&D activities during the first half of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the first half of the current fiscal year were ¥510 million.
  21. FY2019-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current fiscal year were ¥280 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the first quarter of the current fiscal year were ¥280 million.
  22. FY2018RestatedAnnual report

    「R&D on industrial products is currently conducted primarily at the Shizuoka R&D Center, while R&D on household products is conducted primarily at the Ibaraki R&D Center. The Group’s total R&D expenses for the current fiscal year were ¥939 million.」

    The Company continues to operate an R&D structure centered on its Shizuoka and Ibaraki R&D centers, with R&D expenses for the year reported at ¥939 million.
  23. FY2018-Q3RestatedAnnual report

    「Total R&D expenses for the first nine months of the current fiscal year were ¥698 million. There were no material changes in the status of the Group’s R&D activities during the first nine months of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the first nine months of the current fiscal year were ¥698 million.
  24. FY2018-Q2RestatedAnnual report

    「Total R&D expenses for the first half of the current fiscal year were ¥484 million. There were no material changes in the status of the Group’s R&D activities during the first half of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the first half of the current fiscal year were ¥484 million.
  25. FY2018-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current fiscal year were ¥239 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current fiscal year.」

    There were no material changes in R&D activities, and cumulative R&D expenses for the quarter were ¥239 million.
  26. FY2017RestatedAnnual report

    「R&D on industrial products is currently conducted primarily at the Shizuoka R&D Center, while R&D on household products is conducted primarily at the Ibaraki R&D Center. The Group’s total R&D expenses for the current fiscal year were ¥819 million.」

    The Company continues to operate an R&D structure centered on its Shizuoka and Ibaraki R&D centers, with R&D expenses for the year reported at ¥819 million.
  27. FY2017-Q3RestatedAnnual report

    「Total R&D expenses for the first nine months of the current fiscal year were ¥571 million. There were no material changes in the status of the Group’s R&D activities during the first nine months of the current fiscal year.」

    R&D activities continued without material changes, with cumulative R&D expenses for the first nine months reported at ¥571 million.
  28. FY2017-Q2RestatedAnnual report

    「Total R&D expenses for the first half of the current fiscal year were ¥363 million. There were no material changes in the status of the Group’s R&D activities during the first half of the current fiscal year.」

    R&D activities continued without material changes, with cumulative R&D expenses for the quarter reported at ¥363 million.
  29. FY2017-Q1RestatedAnnual report

    「Total R&D expenses for the first quarter of the current fiscal year were ¥182 million. There were no material changes in the status of the Group’s R&D activities during the first quarter of the current fiscal year.」

    R&D activities continued, with R&D expenses for the quarter reported at ¥182 million.
  30. FY2016First statedAnnual report

    「The Company will actively invest in research and development from a long-term perspective, enhance the added value of its products and work to further improve quality.」

    The Company positions R&D investment as a means of creating new businesses, enhancing product added value and improving quality.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Okamoto Industries yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Enhancing Product Value and Quality through R&D Investment | OKAMOTO INDUSTRIES,INC. (5122) | Komori